{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:39Z","timestamp":1786993659944,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","award":["14604\/2021"],"award-info":[{"award-number":["14604\/2021"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","award":["HEC\/SRGP\/836\/2016"],"award-info":[{"award-number":["HEC\/SRGP\/836\/2016"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121198","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T02:18:21Z","timestamp":1668478701000},"page":"121198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"PB","title":["Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects"],"prefix":"10.1016","volume":"311","author":[{"given":"Summaira","family":"Maqsood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar Ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humzah","family":"Jamshaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alam","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunazza","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Gon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.lfs.2022.121198_bb0005","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1017\/S0033291714000282","article-title":"Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study","volume":"44","author":"Morgan","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.lfs.2022.121198_bb0010","first-page":"591","article-title":"Diagnostic and statistical manual of mental disorders","volume":"21","author":"Edition","year":"2013","journal-title":"Am. Psychiatr.Assoc."},{"key":"10.1016\/j.lfs.2022.121198_bb0015","series-title":"The CBHSQ Report","article-title":"Substance use and mental health estimates from the 2013 National Survey on Drug Use and Health: overview of findings","author":"Lipari","year":"2014"},{"key":"10.1016\/j.lfs.2022.121198_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.lfs.2022.121198_bb0025","unstructured":"J. Hartman \"Substance Use and Mental Health in Reintegration Programs.\"."},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10159","key":"10.1016\/j.lfs.2022.121198_bb0035","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121198_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112537","article-title":"Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects","volume":"216","author":"Gul","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.lfs.2022.121198_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120670","article-title":"Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model","volume":"603","author":"Rubab","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.121198_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/02652048.2020.1713242","article-title":"Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product","volume":"37","author":"Khaleeq","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.lfs.2022.121198_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111209","article-title":"Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model","volume":"194","author":"Rana","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.ijir.3900901","article-title":"Levosulpiride: a new solution for premature ejaculation?","volume":"14","author":"Greco","year":"2002","journal-title":"Int. J. Impot. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0070","first-page":"124","article-title":"Levosulpiride in premature ejaculation","volume":"22","author":"Hussain","year":"2010","journal-title":"J.Ayub Med.Coll.Abbottabad"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2016.07.006","article-title":"Comparison of solvent-wetted and kneaded l-sulpiride-loaded solid dispersions: powder characterization and in vivo evaluation","volume":"511","author":"Kim","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.ijir.3900901","article-title":"Levosulpiride: a new solution for premature ejaculation?","volume":"14","author":"Greco","year":"2002","journal-title":"Int. J. Impot. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2004.10.003","article-title":"In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis","volume":"24","author":"Fotaki","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.121198_bb0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.colsurfb.2016.08.010","article-title":"Development of a novel l-sulpiride-loaded quaternary microcapsule: effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability","volume":"147","author":"Kim","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10837450.2017.1419256","article-title":"Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo","volume":"24","author":"Fakhar-ud-Din","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0100","first-page":"129","article-title":"Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability","volume":"9","author":"Ibrahim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNF.0000000000000161","article-title":"Efficacy and safety of levosulpiride versus haloperidol injection in patients with acute psychosis: a randomized double-blind study","volume":"39","author":"Lavania","year":"2016","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0110","first-page":"113","article-title":"Intestinal permeability studies of sulpiride incorporated into self-microemulsifying drug delivery system (SMEDDS)","volume":"24","author":"Chitneni","year":"2011","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0115","first-page":"276","article-title":"Physicochemical modifications and nano particulate strategies for improved bioavailability of poorly water soluble drugs","volume":"5","author":"Siddiqui","year":"2017","journal-title":"Pharm.Nanotechnol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0120","first-page":"309","article-title":"Design, formulation and in vitro evaluation of sustained-release tablet formulations of levosulpiride","volume":"15","author":"Samie","year":"2018","journal-title":"Turk.J.Pharm.Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10837450.2017.1419256","article-title":"Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo","volume":"24","author":"Fakhar ud","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0130","first-page":"3333","article-title":"Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2015.07.011","article-title":"Drug-in-cyclodextrin-in-liposomes: a novel drug delivery system for flurbiprofen","volume":"492","author":"Zhang","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","article-title":"Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art","volume":"87","author":"Gastaldi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40005-019-00462-y","article-title":"Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model","volume":"50","author":"Zeb","year":"2020","journal-title":"J.Pharm.Investig."},{"key":"10.1016\/j.lfs.2022.121198_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/157341309787314665","article-title":"Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases","volume":"5","author":"Baratchi","year":"2009","journal-title":"Curr. Nanosci."},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2022.121198_bb0170","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0175","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/nn501292z","article-title":"Precision nanomedicine in neurodegenerative diseases","volume":"8","author":"Goldsmith","year":"2014","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40005-016-0255-y","article-title":"Nanomedicines for oral administration based on diverse nanoplatform","volume":"46","author":"Sim","year":"2016","journal-title":"J.Pharm.Investig."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.121198_bb0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121198_bb0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpharm.2011.07.035","article-title":"Lipid nanoparticles for brain targeting I. Formulation optimization","volume":"419","author":"Blasi","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.121198_bb0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.colsurfb.2013.04.021","article-title":"Lipid nanoparticles for brain targeting II. Technological characterization","volume":"110","author":"Blasi","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijpharm.2013.06.037","article-title":"Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity","volume":"454","author":"Blasi","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2007.05.060","article-title":"Nanostructured lipid carrier (NLC) based gel of celecoxib","volume":"346","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.lfs.2022.121198_bb0225","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1080\/01932690802701663","article-title":"Effects of chloramphenicol on the characterization of solid lipid nanoparticles and nanostructured lipid carriers","volume":"30","author":"Li","year":"2009","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carbpol.2015.04.071","article-title":"Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion","volume":"130","author":"Rashid","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/02652048.2016.1185475","article-title":"Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation","volume":"33","author":"Mustapha","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.lfs.2022.121198_bb0240","article-title":"Cilostazol-loaded solid lipid nanoparticles: bioavailability and safety evaluation in an animal model","volume":"74","author":"Bibi","year":"2022","journal-title":"J.Drug Deliv.Sci.Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0245","article-title":"Hydroxypropyl-\u03b2-cyclodextrin-based solid dispersed granules: a prospective alternative to conventional solid dispersion","volume":"628","author":"Kim","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.lfs.2022.121198_bb0250","doi-asserted-by":"crossref","first-page":"220428","DOI":"10.1098\/rsos.220428","article-title":"Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis","volume":"9","author":"Khalid","year":"2022","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.lfs.2022.121198_bb0255","first-page":"6147","article-title":"Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe","volume":"10","author":"Rashid","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.lfs.2022.121198_bb0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02652048.2018.1515997","article-title":"Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability","volume":"35","author":"Kim","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.lfs.2022.121198_bb0265","article-title":"Statistically designed dexibuprofen loaded solid lipid nanoparticles for enhanced oral bioavailability","volume":"77","author":"Imran","year":"2022","journal-title":"J.Drug Deliv.Sci.Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.compositesb.2021.109276","article-title":"Novel composite double-layered dressing with improved mechanical properties and wound recovery for thermosensitive drug, Lactobacillus brevis","volume":"225","author":"Yu","year":"2021","journal-title":"Compos. Part B"},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-022-02384-9","article-title":"Antileishmanial agents co-loaded in transfersomes with enhanced macrophage uptake and reduced toxicity","volume":"23","author":"Zahid","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"23","key":"10.1016\/j.lfs.2022.121198_bb0280","doi-asserted-by":"crossref","first-page":"14808","DOI":"10.1039\/D2RA00742H","article-title":"Cisplatin and oleanolic acid co-loaded pH-sensitive CaCO 3 nanoparticles for synergistic chemotherapy","volume":"12","author":"Khan","year":"2022","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.lfs.2022.121198_bb0285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10717544.2011.596583","article-title":"Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration","volume":"18","author":"Wen","year":"2011","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0290","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00394-016-1373-z","article-title":"Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide","volume":"57","author":"Dang","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0295","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch.Int.Pharmacodyn.Ther."},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pbb.2003.11.001","article-title":"Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats","volume":"77","author":"Rex","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"59","key":"10.1016\/j.lfs.2022.121198_bb0305","doi-asserted-by":"crossref","DOI":"10.3791\/3769-v","article-title":"The tail suspension test","author":"Can","year":"2012","journal-title":"J.Vis.Exp."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/biom10030443","article-title":"Succinamide derivatives ameliorate neuroinflammation and oxidative stress in scopolamine-induced neurodegeneration","volume":"10","author":"Iqbal","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0315","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/biom10060816","article-title":"Post-treatment of synthetic polyphenolic 1, 3, 4 oxadiazole compound A3, attenuated ischemic stroke-induced neuroinflammation and neurodegeneration","volume":"10","author":"Mohsin Alvi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2022.121198_bb0320","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fnins.2020.00659","article-title":"Potent natural antioxidant carveol attenuates MCAO-stress induced oxidative, neurodegeneration by regulating the Nrf-2 pathway","volume":"14","author":"Malik","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","article-title":"Techniques for formulation of nanoemulsion drug delivery system: a review","volume":"24","author":"Kumar","year":"2019","journal-title":"Prev.Nutr.Food Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2016.12.010","article-title":"Quality by design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): an improved dermatokinetic profile for inflammatory disorder (s)","volume":"517","author":"Garg","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0335","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/03639045.2021.1890768","article-title":"Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses","volume":"47","author":"Batool","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.lfs.2022.121198_bb0340","first-page":"012001","volume":"vol. 840","author":"Suksaeree","year":"2020"},{"key":"10.1016\/j.lfs.2022.121198_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-017-2249-8","article-title":"ur Rehman, A.; ud Din, F., Nanotechnology: from in vivo imaging system to controlled drug delivery","volume":"12","author":"Mir","year":"2017","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.lfs.2022.121198_bb0350","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2018.11.028","article-title":"Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles","volume":"554","author":"Ana","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0355","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3109\/10717544.2014.993486","article-title":"Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design","volume":"23","author":"Kaur","year":"2016","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.lfs.2022.121198_bb0360","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1208\/s12249-010-9553-2","article-title":"Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)","volume":"11","author":"Sanad","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.colsurfb.2007.06.011","article-title":"Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification","volume":"60","author":"Yuan","year":"2007","journal-title":"Colloids Surf. B. Biointerfaces"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2022.121198_bb0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0375","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15171\/apb.2016.021","article-title":"The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review","volume":"6","author":"Bahari","year":"2016","journal-title":"Adv.Pharm.Bull."},{"key":"10.1016\/j.lfs.2022.121198_bb0380","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"ud Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.lfs.2022.121198_bb0385","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-12-814130-4.00011-7","article-title":"Characterization of nanomaterials: tools and challenges","author":"Mudalige","year":"2019","journal-title":"Nanomater.Food Appl."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.121198_bb0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2010.09.007","article-title":"Development, evaluation and clinical studies of acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"401","author":"Agrawal","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0395","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1620\/tjem.217.231","article-title":"Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A\/MART-1","volume":"217","author":"Song","year":"2009","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.lfs.2022.121198_bb0400","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpba.2015.03.040","article-title":"Evaluating drug delivery with salt formation: drug disproportionation studied in situ by ATR-FTIR imaging and Raman mapping","volume":"111","author":"Ewing","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0405","first-page":"70","article-title":"XRPD-current applications of X-ray powder diffraction in the pharmaceutical industry","volume":"15","author":"Chyall","year":"2012","journal-title":"Am.Pharm.Rev."},{"key":"10.1016\/j.lfs.2022.121198_bb0410","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.11.064","article-title":"Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin","volume":"162","author":"Fathi","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.lfs.2022.121198_bb0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2006.01.040","article-title":"Preparation and characteristics of monostearin nanostructured lipid carriers","volume":"314","author":"Hu","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2022.121198_bb0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jare.2016.03.002","article-title":"Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: design and in vivo study","volume":"7","author":"Shah","year":"2016","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.lfs.2022.121198_bb0425","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.2147\/IJN.S91556","article-title":"Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers","volume":"10","author":"El-Helw","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2022.121198_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejpb.2016.09.008","article-title":"Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery","volume":"108","author":"Qureshi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.lfs.2022.121198_bb0435","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.2147\/IJN.S109088","article-title":"Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression","volume":"11","author":"He","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"issue":"4\u20135","key":"10.1016\/j.lfs.2022.121198_bb0445","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2022.121198_bb0450","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121198_bb0455","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S57565","article-title":"Formulation and delivery of itraconazole to the brain using a nanolipid carrier system","volume":"9","author":"Lim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2022.121198_bb0460","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejpb.2011.10.015","article-title":"Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study","volume":"80","author":"Esposito","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.lfs.2022.121198_bb0465","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"97","key":"10.1016\/j.lfs.2022.121198_bb0470","doi-asserted-by":"crossref","DOI":"10.3791\/52587-v","article-title":"The forced swim test as a model of depressive-like behavior","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J.Vis.Exp."},{"key":"10.1016\/j.lfs.2022.121198_bb0475","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3389\/fphar.2020.01220","article-title":"A potent antioxidant endogenous neurohormone melatonin, rescued MCAO by attenuating oxidative stress-associated neuroinflammation","author":"Ling","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:54:41Z","timestamp":1778633681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522008980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":95,"alternative-id":["S0024320522008980"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121198","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121198"}}